Synthesis and Biological Evaluation of Novel Isoxazole-Amide Analogues as Anticancer and Antioxidant Agents

Table 1

IC₅₀ of isoxazole compounds and doxorubicin on different cancer cells (Hep3B, HeLa, and MCF-7).

		IC50 (μg/ml)
Code	R Group	Hep 3B	Hela	MCF
2a
2b		Inactive
2c		Inactive	Inactive
2d				Inactive
2e
2f			Inactive
2g		Inactive	Inactive	Inactive
DOX

Note: .